{"id":915670,"date":"2025-12-03T10:31:23","date_gmt":"2025-12-03T15:31:23","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/apyx-medical-corporation-announces-approval-and-commercial-launch-of-apyx-one-console-and-single-use-handpieces-for-cosmetic-surgical-procedures-in-south-korea\/"},"modified":"2025-12-03T10:31:23","modified_gmt":"2025-12-03T15:31:23","slug":"apyx-medical-corporation-announces-approval-and-commercial-launch-of-apyx-one-console-and-single-use-handpieces-for-cosmetic-surgical-procedures-in-south-korea","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/apyx-medical-corporation-announces-approval-and-commercial-launch-of-apyx-one-console-and-single-use-handpieces-for-cosmetic-surgical-procedures-in-south-korea\/","title":{"rendered":"Apyx Medical Corporation Announces Approval and Commercial Launch of Apyx One Console and Single-Use Handpieces for Cosmetic Surgical Procedures in South Korea"},"content":{"rendered":"<h2>\nInitial commercial orders for the Apyx One console in South Korea are expected in Q4 2025<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p align=\"justify\">CLEARWATER, Fla., Dec.  03, 2025  (GLOBE NEWSWIRE) &#8212; <strong>Apyx Medical Corporation (Nasdaq: APYX)<\/strong> (the \u201cCompany\u201d or \u201cApyx Medical\u201d) the leader in surgical aesthetics marketed and sold as Renuvion<sup>\u00ae<\/sup> and the AYON Body Contouring System\u2122 (AYON), today announced the approval and commercial launch of the Apyx One console and single-use handpieces in South Korea following the recent regulatory approval by the Ministry of Food and Drug Safety (MFDS). The Company plans to start shipping Apyx One consoles and single-use handpieces to South Korea to fill initial orders starting in the fourth quarter of 2025.<\/p>\n<p align=\"justify\">The Apyx One console is a multi-functional generator incorporating an advanced 3-in-1 energy system that enables plastic and cosmetic surgeons to utilize Renuvion technology, together with full monopolar and bipolar energy. Key features of the Apyx One console include adaptive and intuitive touch screens, procedural presets by body part, quantification of energy delivered to a body area, and an advanced gas system that measures and monitors gas volume and usage.<\/p>\n<p align=\"justify\">\u201cSeoul is widely regarded as the cosmetic surgery capital of the world, supported by a thriving medical tourism industry. We are excited to launch commercial sales of the Apyx One console in South Korea, where the cosmetic surgery market is estimated to be $1.7 billion in 2024 and projected to exceed $3.9 billion by 2033<sup>1<\/sup>,\u201d said Charlie Goodwin, President and CEO of Apyx Medical Corporation. \u201cMuch like in the U.S. and Europe, the GLP-1 weight-loss drug market in South Korea has grown rapidly over the past two years. As a result, we anticipate there to be a growing number of patients seeking solutions for loose and lax skin following significant weight loss. This is an ideal market for our innovative body contouring technology to build on our success across the U.S. and Europe.\u201d<\/p>\n<p align=\"justify\">\n        <em><br \/>\n          <u>Source:<\/u><br \/>\n        <\/em><br \/>\n        <br \/>\n        <em>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a01)\u00a0\u00a0\u00a0 IMARC Group, \u201c<\/em><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MZQ5pZzPX0pzbo49pAot8nklDJAclSEVQwHzpoXE1OWvmsPk7oHJ1xlYQ9WCMrESuSY1MpiVK03DAeiw6wrUx9p8q2Hu5CA_BCSpkzI0xjHpcSPfFU4HQUdlpNWKWfuOsx_dWFDweVNoHUbdyIQUTkJheyPj5FJ6R6Dr8ZNgTRBflvhNqmhoGHLPf4LfBj2W\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <em>South Korea Cosmetic Surgery Market Report, 2024\u20132033<\/em><br \/>\n        <\/a><br \/>\n        <em>\u201d<\/em><\/p>\n<p>        <strong><br \/>\n          <u>Investor Relations Contact<\/u><br \/>\n        <\/strong><br \/>\n        <strong>:<\/strong>\n      <\/p>\n<p align=\"justify\">Jeremy Feffer, Managing Director LifeSci Advisors<br \/>OP: 212-915-2568<br \/><u>jfeffer@lifesciadvisors.com<\/u><\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>About Apyx Medical Corporation<\/u><br \/>\n        <\/strong><br \/>\n        <strong>:<\/strong>\n      <\/p>\n<p align=\"justify\">Apyx Medical Corporation is a surgical aesthetics company with a passion for elevating people\u2019s lives through innovative products, including its Helium Plasma Platform Technology products marketed and sold as Renuvion<sup>\u00ae<\/sup> and the AYON Body Contouring System\u2122\u00a0in the cosmetic surgery market and J-Plasma<sup>\u00ae<\/sup>\u00a0in the hospital surgical market. Renuvion and J-Plasma offer surgeons a unique ability to provide controlled heat to tissue to achieve their desired results. The effectiveness of Renuvion and J-Plasma are supported by more than 90 clinical documents. The AYON Body Contouring System\u00a0is an FDA-cleared, groundbreaking, surgeon-designed body contouring system that combines precision, versatility, and innovation in an all-in-one platform. It seamlessly integrates fat removal, closed loop contouring, tissue contraction, and electrosurgical capabilities, empowering surgeons to deliver the most comprehensive body contouring treatments for patients. The Company also leverages its deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers. For further information about the Company and its products, please refer to the Apyx Medical Corporation website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=sAjU4-UdvYREFdcqw2OVYfWDAwSebaeAYCpeTOzERpkvreNTdHcYZHOypSAtEd6Zz0YWxXyFqo0GdsnogjsCClHwDU8xSDW2vs9Aa31B0KY=\" rel=\"nofollow\" target=\"_blank\">www.ApyxMedical.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>Cautionary Statement on Forward-Looking Statements<\/u><br \/>\n        <\/strong><br \/>\n        <strong>:<\/strong>\n      <\/p>\n<p align=\"justify\">Certain matters discussed in this release and oral statements made from time to time by representatives of the Company may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the Federal securities laws. Although the Company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions, it can give no assurance that its expectations will be achieved.<\/p>\n<p align=\"justify\">All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including but not limited to, statements regarding the Company\u2019s anticipated public offering, including the completion of the public offering on the anticipated terms and the use of proceeds therefrom, projections of net revenue, margins, expenses, net earnings, net earnings per share, or other financial items; projections or assumptions concerning the possible receipt by the Company of any regulatory approvals from any government agency or instrumentality including but not limited to the U.S. Food and Drug Administration (the \u201cFDA\u201d), supply chain disruptions, component shortages, manufacturing disruptions or logistics challenges; or macroeconomic or geopolitical matters and the impact of those matters on the Company\u2019s financial performance.<\/p>\n<p align=\"justify\">Forward-looking statements and information are subject to certain risks, trends and uncertainties that could cause actual results to differ materially from those projected. Many of these factors are beyond the Company\u2019s ability to control or predict. Important factors that may cause the Company\u2019s actual results to differ materially and that could impact the Company and the statements contained in this release include but are not limited to risks, uncertainties and assumptions relating to the regulatory environment in which the Company is subject to, including the Company\u2019s ability to gain requisite approvals for its products from the FDA and other governmental and regulatory bodies, both domestically and internationally; sudden or extreme volatility in commodity prices and availability, including supply chain disruptions; changes in general economic, business or demographic conditions or trends; changes in and effects of the geopolitical environment; liabilities and costs which the Company may incur from pending or threatened litigations, claims, disputes or investigations; and other risks that are described in the Company\u2019s Annual Report on Form 10-K for the fiscal year ended December 31, 2024 and the Company\u2019s other filings with the Securities and Exchange Commission. For forward-looking statements in this release, the Company claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. The Company assumes no obligation to update or supplement any forward-looking statements whether as a result of new information, future events or otherwise.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5NTcxOSM3MzAzMDA5IzUwMDEyOTMwOA==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NjhkNWQ0ZDItMDdmMy00OTZjLTk3N2MtOGUyZDc1Y2ZiMDkwLTUwMDEyOTMwOC0yMDI1LTEyLTAzLWVu\/tiny\/Apyx-Medical-Corporation.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Initial commercial orders for the Apyx One console in South Korea are expected in Q4 2025 CLEARWATER, Fla., Dec. 03, 2025 (GLOBE NEWSWIRE) &#8212; Apyx Medical Corporation (Nasdaq: APYX) (the \u201cCompany\u201d or \u201cApyx Medical\u201d) the leader in surgical aesthetics marketed and sold as Renuvion\u00ae and the AYON Body Contouring System\u2122 (AYON), today announced the approval and commercial launch of the Apyx One console and single-use handpieces in South Korea following the recent regulatory approval by the Ministry of Food and Drug Safety (MFDS). The Company plans to start shipping Apyx One consoles and single-use handpieces to South Korea to fill initial orders starting in the fourth quarter of 2025. The Apyx One console is a multi-functional generator incorporating an advanced &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/apyx-medical-corporation-announces-approval-and-commercial-launch-of-apyx-one-console-and-single-use-handpieces-for-cosmetic-surgical-procedures-in-south-korea\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Apyx Medical Corporation Announces Approval and Commercial Launch of Apyx One Console and Single-Use Handpieces for Cosmetic Surgical Procedures in South Korea&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-915670","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Apyx Medical Corporation Announces Approval and Commercial Launch of Apyx One Console and Single-Use Handpieces for Cosmetic Surgical Procedures in South Korea - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/apyx-medical-corporation-announces-approval-and-commercial-launch-of-apyx-one-console-and-single-use-handpieces-for-cosmetic-surgical-procedures-in-south-korea\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Apyx Medical Corporation Announces Approval and Commercial Launch of Apyx One Console and Single-Use Handpieces for Cosmetic Surgical Procedures in South Korea - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Initial commercial orders for the Apyx One console in South Korea are expected in Q4 2025 CLEARWATER, Fla., Dec. 03, 2025 (GLOBE NEWSWIRE) &#8212; Apyx Medical Corporation (Nasdaq: APYX) (the \u201cCompany\u201d or \u201cApyx Medical\u201d) the leader in surgical aesthetics marketed and sold as Renuvion\u00ae and the AYON Body Contouring System\u2122 (AYON), today announced the approval and commercial launch of the Apyx One console and single-use handpieces in South Korea following the recent regulatory approval by the Ministry of Food and Drug Safety (MFDS). The Company plans to start shipping Apyx One consoles and single-use handpieces to South Korea to fill initial orders starting in the fourth quarter of 2025. The Apyx One console is a multi-functional generator incorporating an advanced &hellip; Continue reading &quot;Apyx Medical Corporation Announces Approval and Commercial Launch of Apyx One Console and Single-Use Handpieces for Cosmetic Surgical Procedures in South Korea&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/apyx-medical-corporation-announces-approval-and-commercial-launch-of-apyx-one-console-and-single-use-handpieces-for-cosmetic-surgical-procedures-in-south-korea\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-03T15:31:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5NTcxOSM3MzAzMDA5IzUwMDEyOTMwOA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apyx-medical-corporation-announces-approval-and-commercial-launch-of-apyx-one-console-and-single-use-handpieces-for-cosmetic-surgical-procedures-in-south-korea\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apyx-medical-corporation-announces-approval-and-commercial-launch-of-apyx-one-console-and-single-use-handpieces-for-cosmetic-surgical-procedures-in-south-korea\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Apyx Medical Corporation Announces Approval and Commercial Launch of Apyx One Console and Single-Use Handpieces for Cosmetic Surgical Procedures in South Korea\",\"datePublished\":\"2025-12-03T15:31:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apyx-medical-corporation-announces-approval-and-commercial-launch-of-apyx-one-console-and-single-use-handpieces-for-cosmetic-surgical-procedures-in-south-korea\\\/\"},\"wordCount\":963,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apyx-medical-corporation-announces-approval-and-commercial-launch-of-apyx-one-console-and-single-use-handpieces-for-cosmetic-surgical-procedures-in-south-korea\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5NTcxOSM3MzAzMDA5IzUwMDEyOTMwOA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apyx-medical-corporation-announces-approval-and-commercial-launch-of-apyx-one-console-and-single-use-handpieces-for-cosmetic-surgical-procedures-in-south-korea\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apyx-medical-corporation-announces-approval-and-commercial-launch-of-apyx-one-console-and-single-use-handpieces-for-cosmetic-surgical-procedures-in-south-korea\\\/\",\"name\":\"Apyx Medical Corporation Announces Approval and Commercial Launch of Apyx One Console and Single-Use Handpieces for Cosmetic Surgical Procedures in South Korea - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apyx-medical-corporation-announces-approval-and-commercial-launch-of-apyx-one-console-and-single-use-handpieces-for-cosmetic-surgical-procedures-in-south-korea\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apyx-medical-corporation-announces-approval-and-commercial-launch-of-apyx-one-console-and-single-use-handpieces-for-cosmetic-surgical-procedures-in-south-korea\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5NTcxOSM3MzAzMDA5IzUwMDEyOTMwOA==\",\"datePublished\":\"2025-12-03T15:31:23+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apyx-medical-corporation-announces-approval-and-commercial-launch-of-apyx-one-console-and-single-use-handpieces-for-cosmetic-surgical-procedures-in-south-korea\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apyx-medical-corporation-announces-approval-and-commercial-launch-of-apyx-one-console-and-single-use-handpieces-for-cosmetic-surgical-procedures-in-south-korea\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apyx-medical-corporation-announces-approval-and-commercial-launch-of-apyx-one-console-and-single-use-handpieces-for-cosmetic-surgical-procedures-in-south-korea\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5NTcxOSM3MzAzMDA5IzUwMDEyOTMwOA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5NTcxOSM3MzAzMDA5IzUwMDEyOTMwOA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apyx-medical-corporation-announces-approval-and-commercial-launch-of-apyx-one-console-and-single-use-handpieces-for-cosmetic-surgical-procedures-in-south-korea\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Apyx Medical Corporation Announces Approval and Commercial Launch of Apyx One Console and Single-Use Handpieces for Cosmetic Surgical Procedures in South Korea\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Apyx Medical Corporation Announces Approval and Commercial Launch of Apyx One Console and Single-Use Handpieces for Cosmetic Surgical Procedures in South Korea - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/apyx-medical-corporation-announces-approval-and-commercial-launch-of-apyx-one-console-and-single-use-handpieces-for-cosmetic-surgical-procedures-in-south-korea\/","og_locale":"en_US","og_type":"article","og_title":"Apyx Medical Corporation Announces Approval and Commercial Launch of Apyx One Console and Single-Use Handpieces for Cosmetic Surgical Procedures in South Korea - Market Newsdesk","og_description":"Initial commercial orders for the Apyx One console in South Korea are expected in Q4 2025 CLEARWATER, Fla., Dec. 03, 2025 (GLOBE NEWSWIRE) &#8212; Apyx Medical Corporation (Nasdaq: APYX) (the \u201cCompany\u201d or \u201cApyx Medical\u201d) the leader in surgical aesthetics marketed and sold as Renuvion\u00ae and the AYON Body Contouring System\u2122 (AYON), today announced the approval and commercial launch of the Apyx One console and single-use handpieces in South Korea following the recent regulatory approval by the Ministry of Food and Drug Safety (MFDS). The Company plans to start shipping Apyx One consoles and single-use handpieces to South Korea to fill initial orders starting in the fourth quarter of 2025. The Apyx One console is a multi-functional generator incorporating an advanced &hellip; Continue reading \"Apyx Medical Corporation Announces Approval and Commercial Launch of Apyx One Console and Single-Use Handpieces for Cosmetic Surgical Procedures in South Korea\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/apyx-medical-corporation-announces-approval-and-commercial-launch-of-apyx-one-console-and-single-use-handpieces-for-cosmetic-surgical-procedures-in-south-korea\/","og_site_name":"Market Newsdesk","article_published_time":"2025-12-03T15:31:23+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5NTcxOSM3MzAzMDA5IzUwMDEyOTMwOA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apyx-medical-corporation-announces-approval-and-commercial-launch-of-apyx-one-console-and-single-use-handpieces-for-cosmetic-surgical-procedures-in-south-korea\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apyx-medical-corporation-announces-approval-and-commercial-launch-of-apyx-one-console-and-single-use-handpieces-for-cosmetic-surgical-procedures-in-south-korea\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Apyx Medical Corporation Announces Approval and Commercial Launch of Apyx One Console and Single-Use Handpieces for Cosmetic Surgical Procedures in South Korea","datePublished":"2025-12-03T15:31:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apyx-medical-corporation-announces-approval-and-commercial-launch-of-apyx-one-console-and-single-use-handpieces-for-cosmetic-surgical-procedures-in-south-korea\/"},"wordCount":963,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apyx-medical-corporation-announces-approval-and-commercial-launch-of-apyx-one-console-and-single-use-handpieces-for-cosmetic-surgical-procedures-in-south-korea\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5NTcxOSM3MzAzMDA5IzUwMDEyOTMwOA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apyx-medical-corporation-announces-approval-and-commercial-launch-of-apyx-one-console-and-single-use-handpieces-for-cosmetic-surgical-procedures-in-south-korea\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/apyx-medical-corporation-announces-approval-and-commercial-launch-of-apyx-one-console-and-single-use-handpieces-for-cosmetic-surgical-procedures-in-south-korea\/","name":"Apyx Medical Corporation Announces Approval and Commercial Launch of Apyx One Console and Single-Use Handpieces for Cosmetic Surgical Procedures in South Korea - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apyx-medical-corporation-announces-approval-and-commercial-launch-of-apyx-one-console-and-single-use-handpieces-for-cosmetic-surgical-procedures-in-south-korea\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apyx-medical-corporation-announces-approval-and-commercial-launch-of-apyx-one-console-and-single-use-handpieces-for-cosmetic-surgical-procedures-in-south-korea\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5NTcxOSM3MzAzMDA5IzUwMDEyOTMwOA==","datePublished":"2025-12-03T15:31:23+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apyx-medical-corporation-announces-approval-and-commercial-launch-of-apyx-one-console-and-single-use-handpieces-for-cosmetic-surgical-procedures-in-south-korea\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/apyx-medical-corporation-announces-approval-and-commercial-launch-of-apyx-one-console-and-single-use-handpieces-for-cosmetic-surgical-procedures-in-south-korea\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apyx-medical-corporation-announces-approval-and-commercial-launch-of-apyx-one-console-and-single-use-handpieces-for-cosmetic-surgical-procedures-in-south-korea\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5NTcxOSM3MzAzMDA5IzUwMDEyOTMwOA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5NTcxOSM3MzAzMDA5IzUwMDEyOTMwOA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apyx-medical-corporation-announces-approval-and-commercial-launch-of-apyx-one-console-and-single-use-handpieces-for-cosmetic-surgical-procedures-in-south-korea\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Apyx Medical Corporation Announces Approval and Commercial Launch of Apyx One Console and Single-Use Handpieces for Cosmetic Surgical Procedures in South Korea"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/915670","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=915670"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/915670\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=915670"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=915670"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=915670"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}